Deep Tech Expertise Bolsters Innovate BC Board; Quantum Computing Takes Center Stage
The selection of the new Innovate BC Board of Directors signals a clear strategic intent: to solidify British Columbia’s positioning at the apex of deeply technical, frontier industries. The additions, particu...
The selection of the new Innovate BC Board of Directors signals a clear strategic intent: to solidify British Columbia’s positioning at the apex of deeply technical, frontier industries. The additions, particularly Andrew Fursman, CEO of 1QBit, introduce focused, high-stakes expertise in quantum computing, significantly strengthening the advisory capacity for the province’s deep tech economy. Fursman’s background goes far beyond theoretical knowledge; his leadership at 1QBit is tied to developing practical tools like the Topological Quantum Architecture Design (TopQAD™️), which has attracted substantial institutional backing, including over $3.4 million from federal and provincial sources. This suggests a maturity level in the quantum space, moving from pure research toward commercial application.
This technical depth is complemented by sector mastery from the other appointees. Nancy Harrison brings three decades of experience in life sciences venture capital, a crucial counterpoint to the quantum focus. Her history with MSI Methylation Sciences and scaling Ventures West’s life sciences portfolio to over $800 million in assets under management provides a proven blueprint for commercializing complex biological technologies. Meanwhile, Dr. Ray Muzyka, a co-founder of BioWare and former physician, grounds the group in early-stage, health-focused venture development.
Collectively, this composition—combining quantum frontier experience, deep life sciences commercialization expertise, and robust public policy acumen (from Christina Zacharuk)—creates a powerhouse advisory body. They are positioned not just to advise, but to shepherd the full lifecycle of innovative ventures: from laboratory discovery (policy/academia) through initial private investment (early-stage deep tech) to commercialization and scaling (venture capital/quantum hardware).
The new board structure provides a sophisticated operational nexus, uniquely blending hands-on quantum hardware expertise with long-term, regulated sector commercialization tracks (Life Sciences, HealthTech), signaling a sustained, high-level commitment to deep tech growth in B.C.